164 related articles for article (PubMed ID: 23534743)
1. Exosomes from murine-derived GL26 cells promote glioblastoma tumor growth by reducing number and function of CD8+T cells.
Liu ZM; Wang YB; Yuan XH
Asian Pac J Cancer Prev; 2013; 14(1):309-14. PubMed ID: 23534743
[TBL] [Abstract][Full Text] [Related]
2. Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells.
Zhu L; Oh JM; Gangadaran P; Kalimuthu S; Baek SH; Jeong SY; Lee SW; Lee J; Ahn BC
Front Immunol; 2018; 9():824. PubMed ID: 29740437
[TBL] [Abstract][Full Text] [Related]
3. Murine mammary carcinoma exosomes promote tumor growth by suppression of NK cell function.
Liu C; Yu S; Zinn K; Wang J; Zhang L; Jia Y; Kappes JC; Barnes S; Kimberly RP; Grizzle WE; Zhang HG
J Immunol; 2006 Feb; 176(3):1375-85. PubMed ID: 16424164
[TBL] [Abstract][Full Text] [Related]
4. Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet.
Lussier DM; Woolf EC; Johnson JL; Brooks KS; Blattman JN; Scheck AC
BMC Cancer; 2016 May; 16():310. PubMed ID: 27178315
[TBL] [Abstract][Full Text] [Related]
5. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
Saunderson SC; McLellan AD
J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
[TBL] [Abstract][Full Text] [Related]
6. Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma.
Bu N; Wu H; Sun B; Zhang G; Zhan S; Zhang R; Zhou L
J Neurooncol; 2011 Sep; 104(3):659-67. PubMed ID: 21336773
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of anti-tumor immunity specific to murine glioma by vaccination with tumor cell lysate-pulsed dendritic cells engineered to produce interleukin-12.
Kim CH; Hong MJ; Park SD; Kim CK; Park MY; Sohn HJ; Cho HI; Kim TG; Hong YK
Cancer Immunol Immunother; 2006 Nov; 55(11):1309-19. PubMed ID: 16463038
[TBL] [Abstract][Full Text] [Related]
8. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from CIITA-transfected CT26 cells enhance anti- tumor effects.
Fan W; Tian XD; Huang E; Zhang JJ
Asian Pac J Cancer Prev; 2013; 14(2):987-91. PubMed ID: 23621273
[TBL] [Abstract][Full Text] [Related]
10. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
Aruga A; Aruga E; Cameron MJ; Chang AE
J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
[TBL] [Abstract][Full Text] [Related]
11. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
Yin W; Song Y; Liu Q; Wu Y; He R
Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
[TBL] [Abstract][Full Text] [Related]
13. Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens.
Lertmemongkolchai G; Cai G; Hunter CA; Bancroft GJ
J Immunol; 2001 Jan; 166(2):1097-105. PubMed ID: 11145690
[TBL] [Abstract][Full Text] [Related]
14. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
16. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes.
Margalit M; Shibolet O; Klein A; Elinav E; Alper R; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2005 Jun; 115(3):443-9. PubMed ID: 15688366
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-7 enhances the in vivo anti-tumor activity of tumor-reactive CD8+ T cells with induction of IFN-gamma in a murine breast cancer model.
Yuan CH; Yang XQ; Zhu CL; Liu SP; Wang BC; Wang FB
Asian Pac J Cancer Prev; 2014; 15(1):265-71. PubMed ID: 24528037
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
19. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
[TBL] [Abstract][Full Text] [Related]
20. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
